BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32437637)

  • 1. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
    Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
    Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension in patients with neurofibromatosis type I.
    Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
    Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D
    Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension associated with neurofibromatosis type 1.
    Jutant EM; Girerd B; Jaïs X; Savale L; O'Connell C; Perros F; Sitbon O; Humbert M; Montani D
    Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.
    Launay D; Hachulla E; Hatron PY; Jais X; Simonneau G; Humbert M
    Medicine (Baltimore); 2007 Sep; 86(5):299-315. PubMed ID: 17873760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
    Stewart DR; Cogan JD; Kramer MR; Miller WT; Christiansen LE; Pauciulo MW; Messiaen LM; Tu GS; Thompson WH; Pyeritz RE; Ryu JH; Nichols WC; Kodama M; Meyrick BO; Ross DJ
    Chest; 2007 Sep; 132(3):798-808. PubMed ID: 17573495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and outcome of pulmonary arterial hypertension patients carrying a
    Thoré P; Girerd B; Jaïs X; Savale L; Ghigna MR; Eyries M; Levy M; Ovaert C; Servettaz A; Guillaumot A; Dauphin C; Chabanne C; Boiffard E; Cottin V; Perros F; Simonneau G; Sitbon O; Soubrier F; Bonnet D; Remy-Jardin M; Chaouat A; Humbert M; Montani D
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32079640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.
    Dauriat G; Reynaud-Gaubert M; Cottin V; Lamia B; Montani D; Canuet M; Boissin C; Tromeur C; Chaouat A; Degano B; Bergot E; Sanchez O; Prevot G; Sitbon O; Thabut G; Belhadi D; de Beauregard YC; Bencherif A; Humbert M; Simonneau G; Laouenan C; Mal H
    J Heart Lung Transplant; 2021 Sep; 40(9):1009-1018. PubMed ID: 34218966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension in Patients with Common Variable Immunodeficiency.
    Thoré P; Jaïs X; Savale L; Dorfmuller P; Boucly A; Devilder M; Meyrignac O; Pichon J; Mankikian J; Riou M; Boiffard E; Boissin C; De Groote P; Chabanne C; Gagnadoux F; Bergeron A; Noel N; Sitbon O; Humbert M; Montani D
    J Clin Immunol; 2021 Oct; 41(7):1549-1562. PubMed ID: 34110542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double-lung transplantation in 15 patients with pulmonary hypertension].
    López-Meseguer M; Román A; Monforte V; Bravo C; Solé J; Morell F
    Arch Bronconeumol; 2009 Aug; 45(8):366-70. PubMed ID: 19410347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.
    Simeoni S; Puccetti A; Chilosi M; Tinazzi E; Prati D; Corrocher R; Lunardi C
    J Med Invest; 2007 Aug; 54(3-4):354-8. PubMed ID: 17878687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis-associated pulmonary hypertension: an ominous duo.
    Coelho SG; Loureiro MJ
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32665279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Hypertension Complicating Fibrosing Mediastinitis.
    Seferian A; Steriade A; Jaïs X; Planché O; Savale L; Parent F; Amar D; Jovan R; Fadel E; Sitbon O; Simonneau G; Humbert M; Montani D
    Medicine (Baltimore); 2015 Nov; 94(44):e1800. PubMed ID: 26554778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal cardiomyopathy in neurofibromatosis type I: Novel phenotype and review of the literature.
    Ritter A; Cuddapah S; Degenhardt K; Kasperski S; Johnson MP; O'Connor MJ; Ahrens-Nicklas R
    Am J Med Genet A; 2019 Jun; 179(6):1042-1046. PubMed ID: 30919579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: A case report.
    Küçük M; Öncel CR; Uçar M; Yıldırım AB
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):458-461. PubMed ID: 28694401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.
    Giannakoulas G; Savvoulidis P; Grosomanidis V; Mouratoglou SA; Karvounis H; Hadjimiltiades S
    BMC Pulm Med; 2016 Dec; 16(1):175. PubMed ID: 27927206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.